Honghua Xiaoyao tablet combined with estradiol improves ovarian function in D-galactose-induced aging mice by reducing apoptosis and affecting the release of reproductive hormones: an in vivo study.
Autor: | Su C; Department of Gynecology, Provincial Hospital, Affiliated to Shandong First Medical University, Jinan, China.; Department of Gynecology, Taiyuan Maternal and Child Health Hospital, Taiyuan, China., Zhang R; Key Laboratory of Experimental Teratology, Ministry of Education, Department of Histology and Embryology, School of Medicine, Shandong University, Jinan, China., Zhang X; Department of Gynecology, Provincial Hospital, Affiliated to Shandong First Medical University, Jinan, China., Feng X; Key Laboratory of Experimental Teratology, Ministry of Education, Department of Histology and Embryology, School of Medicine, Shandong University, Jinan, China., Wu Q; The Second Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan, China., Gao Y; The Second Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan, China., Hao J; Key Laboratory of Experimental Teratology, Ministry of Education, Department of Histology and Embryology, School of Medicine, Shandong University, Jinan, China., Mu YL; Department of Gynecology, Provincial Hospital, Affiliated to Shandong First Medical University, Jinan, China. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in pharmacology [Front Pharmacol] 2024 Jun 06; Vol. 15, pp. 1394941. Date of Electronic Publication: 2024 Jun 06 (Print Publication: 2024). |
DOI: | 10.3389/fphar.2024.1394941 |
Abstrakt: | Context: It is very necessary to delay ovarian aging and prevent age-related health problems. The active ingredient in Honghua Xiaoyao tablet (HHXYT) has the effects of anti-oxidation, anti-inflammation, immune regulation and so on. Objective: To explore the effect and mechanism of Honghua Xiaoyao tablet on aging model mice. Materials and methods: The aging model was established by intraperitoneal injection of D-galactose in model mice. The mice in the HHXYT-L,M,H group were given 0.3 g/kg, 0.6 g/kg and 1.2 g/kg Honghua Xiaoyao tablet suspension respectively, and the HHXYT-M + E2 group was given 0.6 g/kg HHXYT +0.13 mg/kg estradiol valerate for 30 days. In this study, ELISA, HE, Western blot, IH and TUNEL were used. Results: HHXYT + E2 can improve the gonadal index, estrous cycle of aging mice. In HHXYT-M + E2 group, the level of FSH and LH decreased, while E2 and AMH increased significantly. The number of growing follicles in HHXYT-M + E2 group increased, which was better than that of HHXYT alone. Western blot results showed that HHXYT-M + E2 group decreased the expression of Bax, cleaved-Parp, cleaved-Casp-3 and CytC molecules and increased the expression of Bcl-2 in ovarian tissue. FSHR expression decreased in model group and increased in HHXYT group. TUNEL staining showed that the number of apoptotic cells in HHXYT group was reduced, and the HHXYT-M + E2 group was the most significantly. Discussion and conclusion: HHXYT can improve the level of sex hormones and increase the number of growing follicles in aging mice. HHXYT-M + E2 group has the best effect, and its mechanism may be related to reducing ovarian granulosa cell apoptosis. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2024 Su, Zhang, Zhang, Feng, Wu, Gao, Hao and Mu.) |
Databáze: | MEDLINE |
Externí odkaz: |